References

1. 1.
   LIU L P，WU Q，CHEN Y P，et al.Updated pharmacological effects，molecular mechanisms，and therapeutic potential of natural product geniposide［J］.Molecules，2022，27（10）：3319.
2. 2.
   XU C K，ZHANG C B，YANG J P，et al.Textual research on gardeniae fructus［J］.Chin J Exp Tradit Med Form，2020，26（16）：183-191.
3. 3.
   ZHANG J H，HU T，ZHOU X W，et al.Research progress on the pharmacological effects and clinical application of Zhizi（Gardeniae Fructus）［J］.J Liaoning Univ Tradit Chin Med，2024，26（5）：93-98.
4. 4.
   CHEN R，HE Z X，YAN Y，et al.Research progress on pharmacological and toxic effects of Gardeniae Fructus and its main components［J］.Chin Tradit Herb Drugs，2023，54（18）：6092-6105.
5. 5.
   Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China：Volume 1［M］.Beijing：Chinese Medical Science Press，2020：259-260.
6. 6.
   ZHENG H R，CHU Y，LI W，et al.Research progress on pharmacokinetics of natural iridoids［J］.Drug Eval Res，2018，41（6）：1147-1153.
7. 7.
   XU Y P，CHEN L Y，LIU W L，et al.Advances in inflammaging in liver disease［J］.J Zhejiang Univ Med Sci，2025，54（1）： 90-98.
8. 8.
   CHEN G，FAN L Q，YANG T，et al.Prognostic nutritional index（PNI） and risk of non-alcoholic fatty liver disease and advanced liver fibrosis in US adults：Evidence from NHANES 2017-2020［J］.Heliyon，2024，10（4）：e25660.
9. 9.
   ZHU L，XUE C Y.Research progress of Keap1-Nrf2 signaling pathway in the prevention and treatment of acute UV damage in cornea［J］.Mil Med J Southeast China，2021，23（6）：637-641.
10. 10.
    LIU D，LIU Y，HAO Z F.Research progress of miRNAs in improving lipid metabolism disorders by regulating AMPK signaling pathway［J］.Hebei Med J，2023，45（10）：1564-1569.
11. 11.
    SHEN B Y，FENG H H，CHENG J Q，et al.Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways［J］.J Cell Mol Med，2020，24（9）：5097-5108.
12. 12.
    YANG L，BI L P，JIN L L，et al.Geniposide ameliorates liver fibrosis through reducing oxidative stress and inflammatory respose，inhibiting apoptosis and modulating overall metabolism［J］.Front Pharmacol，2021，12：772635.
13. 13.
    WEN M，LIU Y B，CHEN R Y，et al.Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis［J］.Phytother Res，2021，35（7）：3799-3811.
14. 14.
    HUANG W J，XIE X L，SHENG Y M.Pharmacological effects and preparation development progress of verbascoside［J］.Chin Tradit Herb Drugs，2024，55（23）：8256-8268.
15. 15.
    CHEN X Y，JIANG W W，LIU Y L，et al.Anti-inflammatory action of geniposide promotes wound healing in diabetic rats［J］.Pharm Biol，2022，60（1）：294-299.
16. 16.
    DENG R，LI F，WU H，et al.Anti-inflammatory mechanism of geniposide：Inhibiting the hyperpermeability of fibroblast-like synoviocytes via the RhoA/p38 MAPK/NF-κB/F-actin signal pathway［J］.Front Pharmacol，2018，9：105.
17. 17.
    MO F F，ZHOU J J，JIN L L，et al.Gardenoside anti-inflammatory activity in a rat model of ulcerative colitis by regulation of AMPK/ML-CK signaling［J］.Zhejiang J Integr Tradit Chin West Med，2021，31（5）：418-424.
18. 18.
    XU B，LI Y L，XU M，et al.Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function［J］.Acta Pharmacol Sin，2017，38（5）：688-698.
19. 19.
    ZHUGE X J，JIN X S，JI T T，et al.Geniposide ameliorates dextran sulfate sodium-induced ulcerative colitis via KEAP1-Nrf2 signaling pathway［J］.J Ethnopharmacol，2023，314：116626.
20. 20.
    FANG S L，LIU Y C，ZHANG Q H，et al.Study on the analgesic and anti-inflammatory effects of geniposide［J］.Lishizhen Med Mater Med Res，2008，19（6）：1374-1376.
21. 21.
    YANG Y，YANG G，ZENG X Y.Analgesic effect of geniposide and its underlying mechanisms［J］.Med J Chin People's Armed Police Forces，2013，24（3）：218-220.
22. 22.
    WANG M Y.Study on analgesic effect and mechanism of geniposide on inflammatory pain［D］.Nanjing：Nanjing University Of Chinese Medicine，2022.
23. 23.
    JIN G J，YE Q，XU Z L.The analgsic effect and possible mechanisms of Geniposide on type Ⅱ collagen-induced arthritis in rats［J］.Chin J New Drugs，2018，27（3）：356-360.
24. 24.
    ZHANG D D.Geniposide lelieves neuropathic pain in CCI rats by inhibiting the EGFR/PI3K/Akt pathway and Ca²⁺ channels［D］.Hangzhou：Zhejiang Chinese Medical University，2023.
25. 25.
    SCHELTENS P，DE STROOPER B，KIVIPELTO M，et al.Alzheimer's disease［J］.Lancet，2021，397（10284）：1577-1590.
26. 26.
    YANG Z Z，LEI P.Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders［J］.Sci China Life Sci，2025，55（2）：189-205.
27. 27.
    YE J X，HUANG Q H.Research progress on regulation of β-amyloid protein in alzheimer′s disease by geniposide［J］.Liaoning J Tradit Chin Med，2023，50（11）：249-252.
28. 28.
    YE J X，WU J Y，AI L，et al.Geniposide effectively safeguards HT22 cells against Aβ-induced damage by activating mitophagy via the PINK1/Parkin signaling pathway［J］.Biochem Pharmacol，2024，226：116296.
29. 29.
    LIU D X，ZHANG D，HU W M，et al.Geniposide protection against Aβ_1-42 toxicity correlates with mTOR inhibition and enhancement of autophagy［J］.J Integr Neurosci，2021，20（1）：67-75.
30. 30.
    XIANG S T，XU S W，XIAO H，et al.Geniposide exerts neuroprotective effect in Aβ_25-35-induced Alzheimer's disease rat model via ERK1/2-Nrf2 signaling pathway［J］.Acta Med Univ Sci Technol Huazhong，2018，47（1）：27-32.
31. 31.
    CUI L X.Studies on the Mechanisms of geniposide in the anti-depressant effect mediated by gut microbiota［D］.Shanghai：Naval Medical University，2022.
32. 32.
    WANG M H，YANG L，CHEN Z L，et al.Geniposide ameliorates chronic unpredictable mild stress induced depression-like behavior through inhibition of ceramide-PP2A signaling via the PI3K/Akt/GSK3β axis［J］.Psychopharmacology，2021，238（10）：2789-2800.
33. 33.
    CHEN G H，CHEN Q，ZHANG L L，et al.Effects of gardeniin on the expression of collapsin response mediator protein 2 and potential molecular mechanism in prefrontal cortex of depression model rats［J］.Front Pharm Sci，2021，24（10）：1794-1799.
34. 34.
    TAN H M，ZHOU L，ZOU H C.Geniposide-mediated GLP-1R/Akt signaling pathway improves cerebral ischemia-reperfusion injury and neuronal apoptosis in rats［J］.Drug Eval Res，2022，45（9）：1822-1829.
35. 35.
    ZHOU S，LI H M，ZHANG H H，et al.Effect of baicalin-geniposide compatibility on the brain tissue injury in rats with focal cerebral ischemia-reperfusion via LTB4/BLTR pathway［J］.Cent South Pharm，2022，20（6）：1255-1261.
36. 36.
    LIU Z，ZHONG J Y，GAO E N，et al.Synergistic protective effects of gardenoside，ligustrazine and puerarin on ischemia-reperfusion-induced cerebral injury［J］.Chin Tradit Pat Med，2020，42（7）：1754-1759.
37. 37.
    LI H Y，YANG D H，ZHANG Y M，et al.Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury［J］.Chin Med，2022，17（1）：73.
38. 38.
    MA J A，LIU X M，DENG J F，et al.Protective effect of geniposide against myocardial ischemia reperfusion injuries and its relationship with PI3K/Akt signaling pathway in rats［J］.J Clin Exp Med，2018，17（20）：2152-2155.
39. 39.
    MA X F，JIAO Y R，ZHANG J J.Effects of geniposide on inflammatory response，oxidative stress，and PI3K/Akt signal pathway in rats with hepatic ischemia-reperfusion injury［J］.Drugs Clin，2023，38（1）：29-36.
40. 40.
    HANG W D，BAN J Y，ZHAO Z Y，et al.Geniposide protects against lung ischemia-reperfusion injury by modulating p-Akt and NF-κB expression［J］.Chin Community Doctors，2019，35（4）：5-6.
41. 41.
    CHEN F，WANG Y，LI L S.Protective effects of geniposide on renal ischemic reperfusion injury in mice［J］.Pharm J Chin People's Liberation Army，2017，33（6）：550-553.
42. 42.
    GUI K H，ZHANG H Y，HUANG L，et al.Effects of geniposide on the edema and neuronal apoptosis in spinal cord ischemia/reperfusion injury［J］.J Clin Exp Med，2017，16（12）：1157-1160.
43. 43.
    YU X，WANG Y，TAO S J，et al.Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines［J］.Exp Mol Pathol，2020，112：104349.
44. 44.
    ZHANG C，WANG N，TAN H Y，et al.Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1α-independent VEGF expression and angiogenesis in hepatocellular carcinoma［J］.Br J Pharmacol，2020，177（14）：3240-3257.
45. 45.
    SHI Y L，ZHOU P，WANG X K，et al.Regulation of geniposideon on the proliferation，pyroptosis and invasion of breast cancer cells through AMPK/SIRT1/NF-κB pathway［J］.J Guangxi Med Univ，2022，39（11）：1700-1705.
46. 46.
    ZHU L，LIU Z W，CUI Q W，et al.Epigenetic modification of CD⁴⁺ T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment［J］.Cell Death Dis，2024，15（9）：689.
47. 47.
    WU J，WU J，XIAO K，et al.Effect of geniposide regulating PI3K/Akt/mTOR signaling pathway on Th17/Treg function during atherogenesis［J］.Chin J Integr Med Cardio-Cerebrovasc Dis，2024，22（5）：817-822.
48. 48.
    YANG X D.Based on P2RY12 receptor mediated PI3K/Akt/mTOR autophagy signal pathway to explore the mechanism of GP intervention on AS［D］.Guangzhou：Guangzhou University of Chinese Medicine，2023.
49. 49.
    HE P K，WANG H，CHENG S B，et al.Geniposide ameliorates atherosclerosis by regulating macrophage polarization via perivascular adipocyte-derived CXCL14［J］.J Ethnopharmacol，2023，314：116532.
50. 50.
    XIAO Y S，ZHANG S S，YE Y J，et al.Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-κB signaling pathway［J］.J Orthop Surg Res，2023，18（1）：641.
51. 51.
    HUANG J S，YE Y J，XIAO Y S，et al.Geniposide ameliorates glucocorticoid-induced osteoblast apoptosis by activating autophagy［J］.Biomed Pharmacother，2022，155：113829.
52. 52.
    XIAO Y S，REN Q，ZHENG Y Z，et al.Geniposide ameliorated dexamethasone-induced endoplasmic reticulum stress and mitochondrial apoptosis in osteoblasts［J］.J Ethnopharmacol，2022，291：115154.
53. 53.
    ZHENG Y Z，XIAO Y S，ZHANG D，et al.Geniposide ameliorated dexamethasone-induced cholesterol accumulation in osteoblasts by mediating the GLP-1R/ABCA1 axis［J］.Cells，2021，10（12）：3424.
54. 54.
    XIE B C，WU J H，LI Y M，et al.Geniposide alleviates glucocorticoid-induced inhibition of osteogenic differentiation in MC3T3-E1 cells by ERK pathway［J］.Front Pharmacol，2019，10：411.
55. 55.
    ZHANG H Y.Geniposide/bmcalin cardiovascular function and applied to the stent coatings［D］.Chengdu：Southwest Jiaotong University，2014.
56. 56.
    WANG Y F，XU Q H，DUAN M L.Regulatory effect of geniposide on influenza virus-induced lung injury in mice based on the TLR3/TRIF pathway［J］.Chin J Virol，2020，36（1）：35-43.
57. 57.
    ZHANG Y S，QI X，LU X Q，et al.Inhibitory effect of geniposide against influenza A/H1N1 virus［J］.J China Pharm Univ，2016，47（2）：204-209.
58. 58.
    CHEN J J，LIU Y，YIN N N，et al.Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis［J］.Int Immunopharmacol，2024，132：111923.
59. 59.
    YIN J B，WANG Y X，FAN S S，et al.Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38 MAPK signaling pathways［J］.PLoS One，2024，19（9）：e309833.
60. 60.
    CHANG R R.Isoflavones influence on pharmacokinetic profiles of main iridoids from cardeniae fructus in rat［D］.Hefei：Anhui University of Traditional Chinese Medicine，2019.
61. 61.
    SUN W Q，CHEN X K，JIANG Y，et al.Research progress on the pharmacokinetics of geniposide［J］.Biol Chem Eng，2022，8（2）：141-143.
62. 62.
    YANG M，CHEN X Y，ZHANG H Y，et al.Pharmacokinetics of geniposide through 4 routes of administration［J］.Chin J New Drugs，2010，19（9）：746-749.
63. 63.
    SHAN M Q，YU S，YAN H，et al.A review on the phytochemistry，pharmacology，pharmacokinetics and toxicology of geniposide，a natural product［J］.Molecules，2017，22（10）：1689.
64. 64.
    ZHENG W H，WANG Y J，LIANG J J，et al.Comparison of pharmacokinetics between reduning injection and geniposide monomer in rats in vivo［J］.Chin J Exp Tradit Med Form，2014，20（3）：95-99.
65. 65.
    GAO A，ZHANG W S，FENG C Q.Absorption，distribution，metabolism and excretion and the hepatotoxicity of geniposide：A research progress［J］.Chin J Pharmacol Toxicol，2022，36（7）：552-558.
66. 66.
    WANG F G，CAO J，HAO J F，et al.Pharmacokinetics，bioavailability and tissue distribution of geniposide following intravenous and peroral administration to rats［J］.Biopharm Drug Dispos，2014，35（2）：97-103.
67. 67.
    HU F D，AN J，LI W，et al.UPLC-MS/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract［J］.J Ethnopharmacol，2015，169：145-155.
68. 68.
    XU Y L，PU Y C，ZHU L D，et al.A pharmacokinetic study of berberin and gardenoside in rats after oral administration of Zhizi Baipi tablet［J］.Prog Mod Biomed，2019，19（5）：834-837.
69. 69.
    JIANG H Y，YAN S M，WU Q H，et al.Research progress of novel preparations of polysaccharides［J］.China J Chin Mater Med，2020，45（19）：4582-4588.
70. 70.
    JAFARI A，DANESHAMOUZ S，GHASEMIYEH P，et al.Ethosomes as dermal/transdermal drug delivery systems：Applications，preparation and characterization［J］.J Liposome Res，2023，33（1）：34-52.
71. 71.
    ALMEIDA B，NAG O K，ROGERS K E，et al.Recent progress in bioconjugation strategies for liposome-mediated drug delivery［J］.Molecules，2020，25（23）：5672.
72. 72.
    FENG H X，LI P S，LIU Y X，et al.Advances in research and application of liposomes［J］.Prog Pharm Sci，2024，48（10）：725-734.
73. 73.
    CAO J，HOU X Q，WANG F G.Optimization on the preparation of gardenoside liposomes by central composite design-response surface method［J］.Her Med，2021，40（6）：797-801.
74. 74.
    LI Z X，ZHU H M，LIU H，et al.Synergistic dual cell therapy for atherosclerosis regression：ROS-responsive bio-liposomes co-loaded with geniposide and emodin［J］.J Nanobiotechnology，2024，22（1）：129.
75. 75.
    WAN J Y，LONG Y，LIU S Y，et al.Geniposide-loaded liposomes for brain targeting：Development，evaluation，and in vivo studies［J］.AAPS Pharm Sci Tech，2021，22（7）：222.
76. 76.
    PAIVA-SANTOS A C，SILVA A L，GUERRA C，et al.Ethosomes as nanocarriers for the development of skin delivery formulations［J］.Pharm Res，2021，38（6）：947-970.
77. 77.
    SONG Y L，HAN T F，LI S S，et al.Preparation of nasal ethosome spray of geniposide and its nasal mucosa permeability in vitro［J］.Chin Tradit Herb Drugs，2013，44（9）：1105-1110.
78. 78.
    DONG W M，JIANG C Z，YE J C，et al.Advances in penetration promoting approach of transdermal drug delivery systems［J］.Chin J New Drugs，2020，29（18）：2089-2097.
79. 79.
    LIANG Y，ZHANG Z R.Research development in transfersome-based drug delivery system［J］.J Sichuan Univ：Med Sci Ed，2021，52（4）：543-547.
80. 80.
    LI Z Q，CHEN X，CAO D Y，et al.Research progress on deformable nanocapsular carrier-transferosomes in transdermal preparations［J］.Her Med，2024，43（8）：1302-1308.
81. 81.
    YAN H，GAO S Q，LUO H T，et al.Preparation of hyaluronic acid-modified geniposide transfersomes gels and its pharmacodynamic evaluation for adjuvant arthritis［J］.Chin Tradit Herb Drugs，2023，54（18）：5867-5879.
82. 82.
    MA P P，LI Q，OU G，et al.The combined therapeutic effects of 5-aminolevulinic acid cubic liquid crystal and light needles for basal cell cancer［J］.Acta Pharm Sin，2021，56（3）：865-871.
83. 83.
    SI Q.Preparation of matrine lipid-based cubic liquid crystalline nanoparticle gel and its pharmacological evaluation study［D］.Beijing：China Academy of Chinese Medical Sciences，2022.
84. 84.
    OUYANG W，HUANG X Y，WANG X Y，et al.Preparation，characterization，and in vitro evaluation of geniposide cubic liquid crystal gel［J］.J Hunan Univ Chin Med，2024，44（1）：38-46.
85. 85.
    ZENG T Y，HUANG X Y，GAO S Q，et al.Comparison of transdermal capability in vitro and rheology between geniposide cubic liquid crystals gel and its ointment［J］.Asia-Pac Tradit Med，2021，17（4）：30-36.
86. 86.
    MCCLEMENTS D J.Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility，stability，and bioactivity of phytochemicals［J］.Biotechnol Adv，2020，38：107287.
87. 87.
    WANG Y T，JIANG S L，WANG H L，et al.A mucoadhesive，thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases［J］.PLoS One，2017，12（12）：e0189478.
88. 88.
    LI H Y，TIAN M L，WANG C L，et al.A novel Thermo-responsive hydrogel system （ THS ） loaded with the active ingredient of Gardenia jasminoides J.Ellis exhibits anti-depressant effects in vivo via intranasal administration［J］.J Drug Deliv Sci Technol，2023，81：104223.
89. 89.
    XU W T，BAE E J，LEE M K.Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells［J］.Int J Nanomed，2018，13：7549-7563.
90. 90.
    SIVADASAN D，RAMAKRISHNAN K，MAHENDRAN J，et al.Solid lipid nanoparticles：Applications and prospects in cancer treatment［J］.Int J Mol Sci，2023，24（7）：6199.
91. 91.
    WANG F G，CAO J，HAO J F，et al.Pharmacokinetics，tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration［J］.J Microencapsul，2014，31（4）：382-389.
92. 92.
    TANG L，WU L，SUN B X，et al.Preparation and evaluation of geniposide phospholipids complex［J］.J Zhejiang Univ Technol，46（1）：110-113.
93. 93.
    WU T，WANG J Y，YE Q Z，et al.Preparation and evaluation of geniposide phospholipid complex［J］.Chin J Pharm：Online Edition，2019，17（1）：1-11.
94. 94.
    TANG L，YU X L，ZHU Z F，et al.Effect of phospholipid complex on the degradation of geniposide by rat intestinal flora in vitro［J］.Chin Pharm J，2018，53（24）：2090-2095.
95. 95.
    LI H S，XI Y F，XIN X，et al.Study on mechanism of gardenoside in treatment of nonalcoholic steatohepatitis based on bile acid signaling pathway［J］.Chin Arch Tradit Chin Med，2023，41（9）：30-36.
96. 96.
    DU Z，QIU J N，GUO Z，et al.Efficacy/hepatoxicity mechanism of geniposide with different doses and courses in the regulation of chronic cholestasis［J］.China J Tradit Chin Med Pharm，2022，37（7）：4048-4053.
97. 97.
    HAN J Q，LIU Z P.Research progress of transdermal drug delivery system［J］.Prog Biomed Eng，2022，43（1）：24-28.
98. 98.
    XIN X Y，XIONG J，MAO D H，et al.Research progress on intranasal mucosal drug delivery for ischemic stroke treatment［J］.J Pract Tradit Chin Med，2025，41（1）：209-214.